SHANGHAI, September 21, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced that two of its thought leaders will present a training session at the EphMRA 2011 Asia Pharmaceutical Market Research Conference September 27-29 at the Kerry Hotel, Pudong, Shanghai.
Simon Li, General Manager, China, and Todd Johnson, Senior Director, Forecasting, will lead a discussion during the training session “Forecasting New Products in China” from 1:30 to 4 on Wednesday, September 28. The workshop will explore the unique challenges presented by forecasting a new product in China. Attendees will gain an improved understanding of the healthcare system in China and what to consider when forecasting commercial potential for a new oncology product in the Chinese market.
Mr. Li has almost two decades of healthcare market research in China. He combines his market research expertise and understanding of the Chinese healthcare market to help customers understand and navigate the Chinese regulatory and market environment.
Mr. Johnson has more than 20 years of experience in the pharmaceutical industry, and he leads Kantar Health’s forecasting team. He has previously held positions at sanofi-aventis in market research, forecasting, managed care, product management and sales leadership.
For more information on the EphMRA 2011 Asia Pharmaceutical Market Research Conference, visit the conference website.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.